7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Scholtysek C et al. | PPARβ/δ governs Wnt signaling and bone turnover. | 2013 | Nat. Med. | pmid:23542786 |
Stuss M et al. | Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. | 2013 | J. Clin. Endocrinol. Metab. | pmid:23543663 |
Winther S et al. | Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease. | 2013 | Clin. Nephrol. | pmid:23547804 |
Peng X et al. | Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. | 2013 | PLoS ONE | pmid:23516466 |
Zhang Y et al. | Expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on osteoclasts and its potential role in rheumatoid arthritis. | 2013 | Clinics (Sao Paulo) | pmid:23778340 |
Liu M et al. | Semen Astragali Complanati- and Rhizoma Cibotii-enhanced bone formation in osteoporosis rats. | 2013 | BMC Complement Altern Med | pmid:23782721 |
Shen Q et al. | Curculigoside promotes osteogenic differentiation of bone marrow stromal cells from ovariectomized rats. | 2013 | J. Pharm. Pharmacol. | pmid:23738728 |
Liao C and Hua Y | Effect of hydrogen sulphide on the expression of osteoprotegerin and receptor activator of NF-κB ligand in human periodontal ligament cells induced by tension-force stimulation. | 2013 | Arch. Oral Biol. | pmid:24200305 |
Fontes JD et al. | Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. | 2013 | Atherosclerosis | pmid:23489346 |
Oliver JL et al. | Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas. | 2013 | Pigment Cell Melanoma Res | pmid:23490134 |
Maïmoun L et al. | Peripubertal female athletes in high-impact sports show improved bone mass acquisition and bone geometry. | 2013 | Metab. Clin. Exp. | pmid:23490587 |
Cao H et al. | Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. | 2013 | Ann. Thorac. Surg. | pmid:23870696 |
Dahl JS et al. | Relation of osteoprotegerin in severe aortic valve stenosis to postoperative outcome and left ventricular function. | 2013 | Am. J. Cardiol. | pmid:23871267 |
Zhu J et al. | The influence of g.19124G>a genetic polymorphism in the OPG gene on bone mineral density in Chinese women. | 2013 | Genet Test Mol Biomarkers | pmid:23837846 |
Salbach-Hirsch J et al. | The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-κB ligand/osteoprotegerin complex formation. | 2013 | Biomaterials | pmid:23871544 |
Zhou S et al. | Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. | 2013 | PLoS ONE | pmid:23874840 |
Zhong Z et al. | Comparison of the biological response of osteoblasts after tension and compression. | 2013 | Eur J Orthod | pmid:21402736 |
Napimoga MH et al. | Low doses of 15d-PGJ2 induce osteoblast activity in a PPAR-gamma independent manner. | 2013 | Int. Immunopharmacol. | pmid:23597428 |
Bradaschia-Correa V et al. | Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats. | 2013 | Cell Tissue Res. | pmid:23636419 |
Chandran V et al. | Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis. | 2013 | J. Rheumatol. | pmid:23637322 |
Ming LG et al. | The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro. | 2013 | Endocrinology | pmid:23389955 |
Piatek S et al. | Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis. | 2013 | Maturitas | pmid:23391500 |
Biscetti F et al. | Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients. | 2013 | Hum. Genet. | pmid:22965192 |
Pereira GB et al. | Acute effects of resistance training on cytokines and osteoprotegerin in women with metabolic syndrome. | 2013 | Clin Physiol Funct Imaging | pmid:23383690 |
Benslimane-Ahmim Z et al. | Mechanistic study of the proangiogenic effect of osteoprotegerin. | 2013 | Angiogenesis | pmid:23386104 |
Cody JJ et al. | Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model. | 2013 | Lab. Invest. | pmid:23358109 |
Wang Y et al. | The effect of adenovirus-mediated siRNA targeting BMPR-II on UHMWPE-induced osteoclast formation. | 2013 | Biomaterials | pmid:23079666 |
Giganti MG et al. | Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. | 2012 Oct-Dec | J. Biol. Regul. Homeost. Agents | pmid:23241117 |
Heitzer E et al. | IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. | 2012 Nov-Dec | Pain Physician | pmid:23159968 |
Nuño-Arana I et al. | Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. | 2012 Jul-Aug | Am. J. Hum. Biol. | pmid:22434650 |
Varsavsky M et al. | Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. | 2012 Jul-Aug | J. Androl. | pmid:21903971 |
Dalezis P et al. | Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. | 2012 Jan-Feb | In Vivo | pmid:22210719 |
Ambroszkiewicz J et al. | [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. | 2012 Apr-Jun | Med Wieku Rozwoj | pmid:22971655 |
Mogelvang R et al. | Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. | 2012 | Am. J. Cardiol. | pmid:22100028 |
Chung E and Rylander MN | Response of preosteoblasts to thermal stress conditioning and osteoinductive growth factors. | 2012 | Cell Stress Chaperones | pmid:22116637 |
Li J et al. | Effect of oscillating fluid flow stimulation on osteocyte mRNA expression. | 2012 | J Biomech | pmid:22119108 |
Tanaka M et al. | Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF. | 2012 | Bone Marrow Transplant. | pmid:22120987 |
Blázquez-Medela AM et al. | Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes. | 2012 | Eur. J. Clin. Invest. | pmid:22050177 |
Xu S et al. | Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. | 2012 | Rheumatol. Int. | pmid:22057136 |
Ermakov S et al. | A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma. | 2012 | Osteoporos Int | pmid:22057548 |
Ueland T et al. | TNF revisited: osteoprotegerin and TNF-related molecules in heart failure. | 2012 | Curr Heart Fail Rep | pmid:22453763 |
Bogliolo L et al. | Biomarkers and prognostic stratification in psoriatic arthritis. | 2012 | Reumatismo | pmid:22690385 |
Olesen M et al. | No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. | 2012 | Mol. Cell. Endocrinol. | pmid:22698523 |
Cvija H et al. | Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes. | 2012 | Inflammation | pmid:22699680 |
Liu L et al. | Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin. | 2012 | J Endod | pmid:22703658 |
Nakashima T et al. | New insights into osteoclastogenic signaling mechanisms. | 2012 | Trends Endocrinol. Metab. | pmid:22705116 |
Duarte PM et al. | Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. | 2012 | J. Periodontol. | pmid:21859322 |
Ford ML et al. | FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. | 2012 | Nephrol. Dial. Transplant. | pmid:21750158 |
Chai YC et al. | Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. | 2012 | Biomaterials | pmid:22381474 |
Hudson JB et al. | Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability. | 2012 | Calcif. Tissue Int. | pmid:22382900 |
Singh DK et al. | Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. | 2012 | Diabetes Res. Clin. Pract. | pmid:22386825 |
Jia P et al. | The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat. | 2012 | Eur. J. Pharmacol. | pmid:22387856 |
Eleftheriadis T et al. | Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients. | 2012 | Iran J Kidney Dis | pmid:22388612 |
Heymann MF et al. | Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: comparison between carotid and femoral beds. | 2012 | Cytokine | pmid:22402034 |
Sun C et al. | [Acqusition of full-length gene for rabbit osteoprotegerin]. | 2012 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | pmid:22404020 |
Quan J et al. | Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma. | 2012 | Pathology | pmid:22406484 |
Renno AC et al. | Ultrasound therapy modulates osteocalcin expression during bone repair in rats. | 2012 | Ultrasonics | pmid:21820693 |
Bergström I et al. | Physical training increases osteoprotegerin in postmenopausal women. | 2012 | J. Bone Miner. Metab. | pmid:21823052 |
Wang JQ et al. | [Effects of static magnetic field at different times on the proliferation and differentiation of osteoblasts in vitro]. | 2012 | Zhongguo Gu Shang | pmid:23427595 |
Singh PP et al. | Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors. | 2012 | Biochem. Biophys. Res. Commun. | pmid:22561018 |
Aronis KN et al. | Secretion patterns of circulating osteoprotegerin and response to acute and chronic energy deprivation in young healthy adults. | 2012 | J. Clin. Endocrinol. Metab. | pmid:22563105 |
Djamiatun K et al. | Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. | 2012 | PLoS Negl Trop Dis | pmid:22563509 |
Taddei SR et al. | Role of CCR2 in orthodontic tooth movement. | 2012 | Am J Orthod Dentofacial Orthop | pmid:22284282 |
Karieb S and Fox SW | Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro. | 2012 | Br. J. Nutr. | pmid:22289672 |
Niu YB et al. | The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. | 2012 | Osteoporos Int | pmid:22535190 |
Wieczorek-Baranowska A et al. | Osteocalcin and glucose metabolism in postmenopausal women subjected to aerobic training program for 8 weeks. | 2012 | Metab. Clin. Exp. | pmid:22000586 |
Ostrowska Z et al. | RANKL/RANK/OPG system and bone status in females with anorexia nervosa. | 2012 | Bone | pmid:22001124 |
Kam WW et al. | The 18 kDa translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice. | 2012 | PLoS ONE | pmid:22295097 |
Martin CK et al. | Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. | 2012 | Oral Oncol. | pmid:22265717 |
Reginster JY et al. | Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. | 2012 | Bone | pmid:22270053 |
Garlet GP et al. | Expression analysis of wound healing genes in human periapical granulomas of progressive and stable nature. | 2012 | J Endod | pmid:22244633 |
Makras P et al. | Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis. | 2012 | J. Clin. Endocrinol. Metab. | pmid:22278426 |
Stępień E et al. | Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects. | 2012 | Hypertens. Res. | pmid:22278625 |
Cauley JA | Commentary: A single biomarker in a complex metabolic pathway. | 2012 | Int J Epidemiol | pmid:22933649 |
Deuell KA et al. | RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. | 2012 | J. Vasc. Res. | pmid:22948607 |
Li F et al. | Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. | 2012 | Fitoterapia | pmid:22951288 |
Buckle CH et al. | Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. | 2012 | PLoS ONE | pmid:22952578 |
Shen P et al. | Expression of osteoprotegerin in placenta and its association with preeclampsia. | 2012 | PLoS ONE | pmid:22952959 |
Diercke K et al. | IL-1β and compressive forces lead to a significant induction of RANKL-expression in primary human cementoblasts. | 2012 | J Orofac Orthop | pmid:22955577 |
Chen J et al. | OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. | 2012 | Rheumatol. Int. | pmid:22210270 |
Giannopoulou C et al. | Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis. | 2012 | Acta Odontol. Scand. | pmid:22214279 |
Bloch SL and Sørensen MS | Otosclerosis: a perilabyrinthine threshold phenomenon. | 2012 | Acta Otolaryngol. | pmid:22217131 |
Wang S and Liu YS | [Advance on arterial calcification]. | 2012 | Sheng Li Ke Xue Jin Zhan | pmid:23189619 |
Rashtchizadeh N et al. | Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. | 2012 | Ther Apher Dial | pmid:23190522 |
Pecchi E et al. | A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts. | 2012 | Osteoarthr. Cartil. | pmid:22179028 |
Xue Y et al. | Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. | 2012 | PLoS ONE | pmid:23144698 |
Adamczyk T et al. | Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease. | 2012 | Pol. Arch. Med. Wewn. | pmid:22237719 |
Nyrnes A et al. | Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. | 2012 | Gend Med | pmid:23046763 |
Brandenburg V et al. | Calcification inhibitors in vascular calciphylaxis associated with normal renal function. | 2012 | Thromb. Haemost. | pmid:23092963 |
Ryser MD et al. | Osteoprotegerin in bone metastases: mathematical solution to the puzzle. | 2012 | PLoS Comput. Biol. | pmid:23093918 |
Kleyer A et al. | Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. | 2012 | J. Bone Miner. Res. | pmid:22806960 |
Giaginis C et al. | Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis. | 2012 | Med. Sci. Monit. | pmid:23018352 |
Wang C et al. | Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. | 2012 | J. Bone Miner. Res. | pmid:22807154 |
MartÃnez E et al. | Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. | 2012 | AIDS | pmid:23018438 |
Poerschke RL et al. | Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. | 2012 | J. Biochem. Mol. Toxicol. | pmid:22807314 |
Thadani U | Osteoprotegerin and ST segment myocardial infarction: a novel risk marker but not for routine use at present. | 2012 | Cardiology | pmid:23018624 |
Chandran V | Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. | 2012 | J Rheumatol Suppl | pmid:22751596 |
Melchiorre D et al. | RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology. | 2012 | J. Rheumatol. | pmid:22753650 |
Zhou W and Mei L | Effect of autologous bone marrow stromal cells transduced with osteoprotegerin on periodontal bone regeneration in canine periodontal window defects. | 2012 | Int J Periodontics Restorative Dent | pmid:22754911 |
Baud'huin M et al. | A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:22761317 |